Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
9.57
-0.13 (-1.34%)
At close: Jan 30, 2025, 4:00 PM
9.51
-0.06 (-0.63%)
After-hours: Jan 30, 2025, 4:10 PM EST
Anavex Life Sciences Employees
Anavex Life Sciences had 42 employees as of September 30, 2024. The number of employees increased by 2 or 5.00% compared to the previous year.
Employees
42
Change (1Y)
2
Growth (1Y)
5.00%
Revenue / Employee
n/a
Profits / Employee
-$1,023,857
Market Cap
811.68M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
AVXL News
- 3 days ago - Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio - GlobeNewsWire
- 15 days ago - Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer's Disease - GlobeNewsWire
- 17 days ago - New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer's Disease Patients - GlobeNewsWire
- 18 days ago - Playing The Odds Of Anavex Alzheimer's Drug Approval - Seeking Alpha
- 24 days ago - Anavex Life Sciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Anavex Life Sciences: Jumping In On-Time Ahead Early Alzheimer's Decision - Seeking Alpha
- 5 weeks ago - Kemper To Rally More Than 25%? Here Are 4 Top Analyst Forecasts For Thursday - Benzinga
- 5 weeks ago - Anavex Life Sciences: Why I Am Still Not Buying The Bull Thesis - Seeking Alpha